CC vs. HUN, BCPC, ASH, IOSP, NGVT, OLN, HWKN, PRM, FMC, and FUL
Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include Huntsman (HUN), Balchem (BCPC), Ashland (ASH), Innospec (IOSP), Ingevity (NGVT), Olin (OLN), Hawkins (HWKN), Perimeter Solutions (PRM), FMC (FMC), and H.B. Fuller (FUL). These companies are all part of the "basic materials" sector.
Chemours (NYSE:CC) and Huntsman (NYSE:HUN) are both mid-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.
Huntsman has higher revenue and earnings than Chemours. Huntsman is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.
76.3% of Chemours shares are held by institutional investors. Comparatively, 84.8% of Huntsman shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 6.1% of Huntsman shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, Huntsman had 14 more articles in the media than Chemours. MarketBeat recorded 34 mentions for Huntsman and 20 mentions for Chemours. Huntsman's average media sentiment score of 0.37 beat Chemours' score of 0.13 indicating that Huntsman is being referred to more favorably in the news media.
Chemours received 7 more outperform votes than Huntsman when rated by MarketBeat users. However, 66.49% of users gave Huntsman an outperform vote while only 61.01% of users gave Chemours an outperform vote.
Huntsman has a net margin of -1.49% compared to Chemours' net margin of -5.51%. Chemours' return on equity of 46.67% beat Huntsman's return on equity.
Chemours presently has a consensus price target of $31.63, indicating a potential upside of 15.00%. Huntsman has a consensus price target of $26.73, indicating a potential upside of 6.29%. Given Chemours' stronger consensus rating and higher probable upside, equities research analysts plainly believe Chemours is more favorable than Huntsman.
Chemours has a beta of 1.99, suggesting that its share price is 99% more volatile than the S&P 500. Comparatively, Huntsman has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.
Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 3.6%. Huntsman pays an annual dividend of $1.00 per share and has a dividend yield of 4.0%. Chemours pays out -46.1% of its earnings in the form of a dividend. Huntsman pays out -192.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Huntsman beats Chemours on 13 of the 20 factors compared between the two stocks.
Get Chemours News Delivered to You Automatically
Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chemours Competitors List
Related Companies and Tools
